Biomedical Engineering Reference
In-Depth Information
102. Grundemann D, Harlfinger S, Golz S, Geerts A, Lazar A, Berkels R, Jung N, Rubbert A,
Schomig E. 2005. Discovery of the ergothioneine transporter. Proc Natl Acad Sci U S A
102:5256-5261.
103. 103. Wu X, Prasad PD, Leibach FH, Ganapathy V. 1998. cDNA sequence, transport
function, and genomic organization of human OCTN2, a new member of the organic
cation transporter family. Biochem Biophys Res Commun 246:589-595.
104. Wu X, Huang W, Prasad PD, Seth P, Rajan DP, Leibach FH, Chen J, Conway SJ, Ganap-
athy V. 1999. Functional characteristics and tissue distribution pattern of organic cation
transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther
290:1482-1492.
105. Tamai I, Ohashi R, Nezu J, Yabuuchi H, Oku A, Shimane M, Sai Y, Tsuji A. 1998.
Molecular and functional identification of sodium ion-dependent, high affinity human
carnitine transporter OCTN2. J Biol Chem 273:20378-20382.
106. Nezu J, Tamai I, Oku A, Ohashi R, Yabuuchi H, Hashimoto N, Nikaido H, Sai Y,
Koizumi A, Shoji Y, et al. 1999. Primary systemic carnitine deficiency is caused by
mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet 21:
91-94.
107. Tang NL, Hwu WL, Chan RT, Law LK, Fung LM, Zhang WM. 2002. A founder mutation
(R254X) of SLC22A5 (OCTN2) in Chinese primary carnitine deficiency patients. Hum
Mutat 20:232.
108. Wang Y, Ye J, Ganapathy V, Longo N. 1999. Mutations in the organic cation/carnitine
transporter OCTN2 in primary carnitine deficiency. Proc Natl Acad SciUSA96:2356-
2360.
109. Ohashi R, Tamai I, Inano A, Katsura M, Sai Y, Nezu J, Tsuji A. 2002. Studies on func-
tional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys
mutant protein. J Pharmacol Exp Ther 302:1286-1294.
110. Seth P, Wu X, Huang W, Leibach FH, Ganapathy V. 1999. Mutations in novel organic
cation transporter (OCTN2), an organic cation/carnitine transporter, with differential ef-
fects on the organic cation transport function and the carnitine transport function. J Biol
Chem 274:33388-33392.
111. Sekine T, Kusuhara H, Utsunomiya-Tate N, Tsuda M, Sugiyama Y, Kanai Y, Endou H.
1998. Molecular cloning and characterization of high-affinity carnitine transporter from
rat intestine. Biochem Biophys Res Commun 251:586-591.
112. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. 1987.
Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal
human tissues. Proc Natl Acad SciUSA84:7735-7738.
113. Otsuka M, Matsumoto T, Morimoto R, Arioka S, Omote H, Moriyama Y. 2005. A human
transporter protein that mediates the final excretion step for toxic organic cations. Proc
Natl Acad SciUSA102:17923-17928.
114. Ljubojevic M, Herak-Kramberger CM, Hagos Y, Bahn A, Endou H, Burckhardt G, Sabolic
I. 2004. Rat renal cortical OAT1 and OAT3 exhibit gender differences determined by both
androgen stimulation and estrogen inhibition. Am J Physiol Renal Physiol 287:F124-
F138.
115. Buist SC, Cherrington NJ, Choudhuri S, Hartley DP, Klaassen CD. 2002. Gender-specific
and developmental influences on the expression of rat organic anion transporters. J Phar-
macol Exp Ther 301:145-151.
Search WWH ::
Custom Search